Trial Profile

Evaluation of the Safety and Efficacy of Sintilimab Combined With IBI305 in the Treatment of Advanced Hepatocellular Carcinoma in a Single-center, One-arm, and Phase Ib Study

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 27 Sep 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

22 Jan 2022 Final clinical outcome presented at the 2022 Gastrointestinal Cancers Symposium
21 Jan 2022 According to an Innovent Biologics media release, the company jointly announced with Eli Lilly and Company final clinical outcome and biomarker analysis were presented at the 2022 ASCO Gastrointestinal Cancers Symposium (Abstract# 455).
21 Jan 2022 Final clinical outcome and biomarker analysis published in an Innovent Biologics Media Release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com